Site navigation

Navigation

Hepatitis B - telbivudine

Telbivudine for the treatment of chronic hepatitis B

Summary

Telbivudine is not recommended for people with chronic hepatitis B. Healthcare professionals should not stop prescribing telbivudine for people who were already taking it when the guidance was issued.These patients should be able to carry on taking telbivudine until they and their healthcareprofessi ...

Read the complete summary


We will consult on our review plans for this guidance in February 2009.


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in February 2009

About this guidance

Technology appraisals TA154

Issued: August 2008

How this guidance was produced

See also:

Order printed copies of this guidance